Philip Low
Chairman, CEO and Founder at NeuroVigil.
Dr. Low made his first scientific discovery at Harvard Medical School – as a teenager. While inventing new brain monitoring techniques at the University of Chicago, he was referred to the Salk Institute by Francis Crick, Nobel Laureate of DNA fame, where he authored a 1 page PhD thesis on dynamic brain activity mapping unanimously approved by a committee of two past presidents of the Society for Neuroscience (SfN) and four members of the National Academy of Sciences, including his co-advisors, Drs. Terry Sejnowski and Fred Gage. The thesis work led to his creation of NeuroVigil, the neurotechnology company responsible for iBrainTM, a portable brain activity monitor, with first and second round valuations two and two-and-a-half times Google’s and Facebook’s combined, respectively, as well as to his writing of the Cambridge Declaration on Consciousness, the first formal document officially recognizing consciousness in non-humans – by demonstrating that features thought to be at best unique to the human brain were not necessary for features for which consciousness is thought to be necessary – the signing of which by neuroscientists was described as a “Copernican moment in the history of civilization” which has led to a worldwide debate and to the evolution of the treatment and rights of non-humans.
Visit website: https://neurovigil.com/index.php/about-us/leadership
See also: NeuroVigil - Neurotechnology company focused on the analysis of brain signal or EEG data.
Details last updated 20-Jun-2020
Philip Low News
Exponential Medicine conference day 3 summary
Medgadget - 13-Nov-2015
Practice of medicine needs to become the science of medicine Regenerative and Rejuvenative Medic...
Read more...